|
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) (USD $)
|
3 Months Ended | 6 Months Ended | 184 Months Ended | ||
|---|---|---|---|---|---|
|
Jun. 30, 2013
|
Jun. 30, 2012
|
Jun. 30, 2013
|
Jun. 30, 2012
|
Jun. 30, 2013
|
|
| Income Statement [Abstract] | |||||
| Net sales | $ 0 | $ 0 | $ 0 | $ 0 | $ 69,000 |
| Cost of goods sold | 0 | 0 | 0 | 0 | 24,120 |
| Gross profit | 0 | 0 | 0 | 0 | 44,880 |
| Operating expenses | 1,541,866 | 1,849,814 | 2,754,750 | 3,719,719 | 53,825,055 |
| Research and development expenses | 430,202 | 255,424 | 759,257 | 490,890 | 9,428,938 |
| Non-cash patent settlement cost | 0 | 0 | 0 | 0 | 1,610,066 |
| Loss before other income (expense) | (1,972,068) | (2,105,238) | (3,514,007) | (4,210,609) | (64,819,179) |
| Other income (loss) | 4,950 | 2,384 | (23,895) | 15,975 | 192,800 |
| Interest income | 0 | 0 | 0 | 0 | 16,342 |
| Interest and financing expense | 0 | (351,422) | (260) | (2,814,289) | (20,304,609) |
| Change in fair value of derivative liabilities | 0 | 971,902 | (220,614) | (167,575) | (2,115,507) |
| Gain on extinguishment of derivative liabilities | 0 | 85,576 | 3,441,752 | 85,576 | 5,886,847 |
| Costs of private placement | 0 | 0 | 0 | 0 | (1,640,715) |
| Costs to induce conversion of notes | 0 | 0 | 0 | 0 | (469,043) |
| Loss on disposition of equipment | 46,968 | 0 | 46,968 | 0 | 32,542 |
| Settlement of Debt Due Morale/ Matthews | 0 | 0 | 0 | 0 | (927,903) |
| Settlement of litigation and debt | 0 | 0 | (67,294) | 223,774 | 1,437,503 |
| Loss before provision for income taxes | (1,920,150) | (1,396,798) | (337,350) | (6,867,148) | (82,710,922) |
| Provision for income taxes | 800 | 800 | 800 | 800 | 9,082 |
| Net loss | $ (1,920,950) | $ (1,397,598) | $ (338,150) | $ (6,867,948) | $ (82,720,004) |
| Net income (loss) per common share, basic and diluted | $ (0.01) | $ (0.01) | $ 0.00 | $ (0.06) | |
| Weighted average common shares outstanding, basic and diluted | 159,896,258 | 127,283,585 | 155,084,826 | 122,748,623 | |
| X | ||||||||||
|
- Definition
Total costs related to goods produced and sold during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. No definition available.
|
| X | ||||||||||
|
- Definition
Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Sum of operating profit and nonoperating income or expense before Income or Loss from equity method investments, income taxes, extraordinary items, and noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Interest and debt related expenses associated with nonoperating financing activities of the entity. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees. No definition available.
|
| X | ||||||||||
|
- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
| X | ||||||||||
|
- Definition
Other financial services costs incurred during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Other expenses or losses included in net income that result in no cash outflows or inflows in the period and are not separately disclosed. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The total amount of other operating income, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operation. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The cash outflow for cost incurred directly with the issuance of an equity security. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS). No definition available.
|
| X | ||||||||||
|
- Definition
Gain on extinguishment of derivative liabilities No definition available.
|
| X | ||||||||||
|
- Definition
Settlement of Debt Due Morale/ Matthews No definition available.
|